WEBINAR ON DEMAND
Duration: 1 hour

Pharma companies traditionally rely on payer coverage data, including formularies and restrictions, to understand the contours of their market access barriers. While these inputs are certainly valuable, they can create an incomplete picture. For example, if preferred drugs aren’t the ones being reimbursed by the PBM, it can create a gap between policy and practice. That’s why manufacturers are increasingly relying on real-world data (RWD) to uncover the blind spots in their market access analysis.

How can your pharma company leverage RWD to strengthen your market access strategy? Watch the webinar to learn how. Topics include:

• Common disparities between policy and practice, and how to solve for them
• Opportunities for claims, labs, and other inputs in market access planning
• What to look for in an RWD solution for your market access team
• Best practices when assessing RWD for a more complete access picture

SPEAKERS

Theodore Search, Pharm.D.
General Manager and CEO of Real-World Data
Norstella

Robert G. Petit II, Ph.D., M.D.
CMO/CSO, OS Therapies Inc
EVP of Commercial Operations,
RWD, Norstella

Lance Wolkenbrod
Senior Director of Commercial Solutions
MMIT